Siegel RL, et al. Cancer statistics, 2024. CA Cancer J Clin 2024; 74:12–494. doi: 10.3322/caac.21820
Kidney Diseases: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3(1). https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf
Pasternak M, et al. Association of albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease. JAMA Netw Open 2022; 5:e2225821. doi: 10.1001/jamanetworkopen.2022.25821
Hillege HL, et al.; Prevend Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249:519–526. doi: 10.1046/j.1365-2796.2001.00833.x
Lee M, et al. Level of albuminuria and risk of stroke: Systematic review and meta-analysis. Cerebrovasc Dis 2010; 30:464–469. doi: 10.1159/000317069
Ahn SY, et al. Dipstick proteinuria and cancer incidence: A nationwide population-based study. J Nephrol 2020; 33:1067–1077. doi: 10.1007/s40620-020-00740-1
Tu H, et al. Cancer risk associated with chronic diseases and disease markers: Prospective cohort study. BMJ 2018; 360:k134. doi: 10.1136/bmj.k134
Luo L, et al. Urinary albumin excretion and cancer risk: The PREVEND cohort study. Nephrol Dial Transplant 2023; 38:2723–2732. doi: 10.1093/ndt/gfad107
Luo L, et al. Albuminuria and the risk of cancer: The Stockholm Creatinine Measurements (SCREAM) project. Clin Kidney J 2023; 16:2437–2446. doi: 10.1093/ckj/sfad145